ÂÜÀòÂÒÂ×

Anna Vilborg Hartwig has over 15 years of experience in the biotechnology industry. Anna began their career in 2005 as a Graduate Student and Post Doc at Karolinska Institutet. In 2011, they served as a Post Doc at Yale University. From 2016 to 2018, they worked at TOMA Biosciences as the Vice President R&D, Director of R&D, and Senior Scientist. From 2018 to 2022, they worked at Guardant Health as the Associate Director, Sr. Manager, and Manager. Currently, they are the VP of Product Technology Development at Exai Bio.

Anna Vilborg Hartwig obtained a Doctor of Philosophy (Ph.D.) in Biomedicine from Karolinska Institutet in 2010, after having previously earned an M.Sc. in Biomedicine from the same institution between 2000 and 2005.